The Market for Direct-to-Consumer Genetic Health Testing

 
   Single User - $3,995
   Site License (one location, 10 users) - $5,995
   Corporate License - $7,990



Loading...
Published Jan 10, 2018 | 91 Pages | Pub ID: KLI15569647

The Market for Direct-to-Consumer Genetic Health Testing

The growth of the direct-to-consumer (DTC) genetic testing healthcare market segment is borne out of a paradigm shift among consumers who are seeking greater control over their own healthcare. Kalorama Information's report, The Market for Direct-to-Consumer Genetic Health Testing, provides the reader with an overview of the laboratory testing industry for advanced genetic tests.

Several trends are continuing to shape the direct-to-consumer laboratory testing market, including the growing demand for early disease detection and diagnosis, personalized medicine, importance of disease monitoring and expanded technologies. The Market for Direct-to-Consumer Genetic Health Testing evaluates those trends and provides useful business information.

Market Trends Covered Include:
  • Genetic Testing Market Drivers and Barriers
  • Global DTC Genetic Testing Market, 2017-2022
  • Global Direct-to-Consumer Genetic Testing Market Analysis: Genetic Testing Volume Distribution for Genetic Testing Services, by Order Origination Source (Consumer, Physician)
  • Market Size and Growth for U.S. DTC Genetic Testing Market, 2017-2022
  • Market Size and Growth for European DTC Genetic Testing Market, 2017-2022
  • Market Size and Growth for Asia Pacific DTC Genetic Testing Market, 2017-2022
  • Market Size and Growth for Rest of World DTC Genetic Testing Market, 2017-2022
  • Key Player Revenues
  • DTC Genetic Company Profiles
Included in The Market for Direct-to-Consumer Genetic Health Testing are statistics influencing direct-to-consumer lab testing, incidence of diseases in the U.S. and worldwide, demographics; life expectancy, and genetic testing company strategies. Information is presented as a U.S market report. A market summary includes a total U.S. market analysis and analysis by test segment. Also included are competitive profiles of leading direct-to-consumer laboratory testing providers.

Since the 1980s, consumers have pushed for access to their laboratory tests, but it has been slow to evolve due to concerns that consumers may try to diagnose themselves without understanding how diagnoses' information all fits together. With advances in genetic testing technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct-to-consumer lab testing is becoming increasingly popular. With the increased use of the Internet for medical information, consumers have become medical consumers as well as patients. This has created a change in the doctor/patient relationship as individuals have become more knowledgeable about their own health and want more control over their personal information and treatment decisions.

Larger genetic testing companies such as Quest Diagnostics and LabCorp have advantages in the genetic testing market due to their wide exposure, large number of locations, and greater financial positions but, until recently, had not been directly involved. Smaller, independent laboratories have been the mainstay of the direct-to-consumer laboratory testing market. Some laboratories, such as 23andMe, have found success in offering specialized genetic testing (ancestral testing) and others have found success operating on a regional basis such as Sonora Quest Laboratories. This report provides an overview of some of the leading market participants in the direct to consumer laboratory testing market.
  • 23andMe, Inc
  • Any Lab Test Now, Inc.
  • DNA 4life
  • Eastern Biotech & Life Sciences
  • Easydna
  • Genetrainer
  • GHC Genetics Uk
  • International Biosciences
  • MapMyGenome India
  • Medichecks.Com
  • Pathway Genomics
  • Positive Bioscience
  • Shuwen Biotech Co. Ltd.
  • Vitagene, Inc.
  • Xcode
Related Companies
  • Ambry Genetics Corp.
  • Color Genomics
  • Counsyl, Inc.
  • Genedx
  • Gene By Gene, Ltd.
  • Invitae
  • Natera, Inc
  • Request a Test, Ltd.
  • Veritas Genetics
Affilliated Laboratories
  • Laboratory Corporation Of America
  • Myriad Genetics, Inc.
  • Quest Diagnostics, Inc
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with key industry officials, consultants, healthcare providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.